These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19930230)

  • 21. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy.
    Krause K; Ardelean E; Kessler B; Magerl M; Metz M; Siebenhaar F; Weller K; Worm M; Zuberbier T; Maurer M
    Allergy; 2010 Nov; 65(11):1494-5. PubMed ID: 20560911
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis.
    Kai AC; Flohr C; Grattan CE
    Clin Exp Dermatol; 2014 Jul; 39(5):651-2. PubMed ID: 24758481
    [No Abstract]   [Full Text] [Related]  

  • 23. Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab.
    Vestergaard C; Deleuran M
    Acta Derm Venereol; 2010 Jul; 90(4):443-4. PubMed ID: 20574627
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
    Ensina LF; de Lacerda AE; Machado LM; Camelo-Nunes I; Solé D
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):536. PubMed ID: 26653279
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic Idiopathic Urticaria.
    Wu EY; Saini SS
    J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring of thyroid function in patients who exhibit IgE against thyroperoxidase while taking omalizumab?
    Dreyfus DH
    J Allergy Clin Immunol; 2012 Jan; 129(1):269-70; author reply 270. PubMed ID: 22104608
    [No Abstract]   [Full Text] [Related]  

  • 28. Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints.
    Kutlu A; Tanoglu A; Ozturk S
    Chin Med J (Engl); 2015 Jun; 128(11):1559-60. PubMed ID: 26021519
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of severe heat urticaria with omalizumab - report of a case and review of the literature.
    Bonnekoh H; Terhorst-Molawi D; Buttgereit T; Maurer M; Altrichter S
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e489-e491. PubMed ID: 32237244
    [No Abstract]   [Full Text] [Related]  

  • 30. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

  • 32. Omalizumab treatment in 2 cases of refractory heat urticaria.
    Carballada F; Nuñez R; Martin-Lazaro J; Juárez Y; Castiñeira I; Carballada F; Nuñez R; Martin-Lazaro J; Juárez Y; Castiñeira I; Fernández L; Boquete M
    J Investig Allergol Clin Immunol; 2013; 23(7):519-21. PubMed ID: 24654322
    [No Abstract]   [Full Text] [Related]  

  • 33. Ice cream urticaria.
    Ota M; Kawasaki H; Horimoto M
    Am J Med; 2010 Dec; 123(12):e1-2. PubMed ID: 20961525
    [No Abstract]   [Full Text] [Related]  

  • 34. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A
    Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab and omalizumab in severe, refractory insulin allergy.
    Yong PF; Malik R; Arif S; Peakman M; Amiel S; Ibrahim MA; Gough A
    N Engl J Med; 2009 Mar; 360(10):1045-7. PubMed ID: 19264698
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
    Chicharro P; Rodríguez-Jiménez P; de Argila D
    Actas Dermosifiliogr; 2017 May; 108(4):383-384. PubMed ID: 27914623
    [No Abstract]   [Full Text] [Related]  

  • 37. Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.
    Groffik A; Mitzel-Kaoukhov H; Magerl M; Maurer M; Staubach P
    Allergy; 2011 Feb; 66(2):303-5. PubMed ID: 21208221
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 39. Omalizumab: a novel therapy for allergic asthma.
    Davis LA
    Ann Pharmacother; 2004; 38(7-8):1236-42. PubMed ID: 15187202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.